By Hendra Lukman 
Children’s Hospital Colorado (Children’s Colorado) has successfully performed its first-ever dual heart and liver transplant, a complex and groundbreaking procedure that signifies a monumental achievement for its Pediatric Transplant Program. This intricate surgery, which involved the coordinated efforts of dozens of specialists across 25 multidisciplinary care teams, underscores the hospital’s commitment to providing advanced care for critically ill children. Nationwide, such dual organ transplants in pediatric patients are exceptionally rare, with only 38 recorded instances prior to this significant event.
"Performing Children’s Colorado’s first-ever heart and liver dual organ transplant is an amazing accomplishment for our Pediatric Transplant Program," stated Dr. Megan Adams, surgical director of the Pediatric Liver Transplant and Kidney Transplant Programs. "Thanks to years of dedication and a team committed to being the trusted leaders in pediatric transplant across our seven-state region, we’re grateful to provide this level of care to even more kids who need complex organ transplants to treat life-threatening illnesses and help them live healthy and happy lives." This sentiment highlights the culmination of extensive preparation and the collective expertise of the hospital’s medical professionals.
Years of Dedicated Preparation Pave the Way for a Life-Saving Intervention
The successful dual transplant was not a spontaneous event but rather the result of years of meticulous planning, preparation, and unwavering dedication from the care teams at Children’s Colorado. The hospital’s commitment to advancing its capabilities in complex pediatric transplant surgery was evident in the close coordination among specialists in various critical fields, including surgery, cardiology, hepatology, and other essential medical disciplines. This collaborative environment, bolstered by strong institutional leadership, ensured that the hospital was optimally prepared when an 11-year-old patient, Gracie Greenlaw, and her family required this extraordinary intervention.
Gracie’s medical journey began at birth with a diagnosis of hypoplastic left heart syndrome (HLHS), a severe congenital heart defect characterized by the underdevelopment of the left ventricle, the heart’s main pumping chamber. To manage this life-threatening condition, Gracie underwent three major open-heart surgeries before her third birthday: the Norwood procedure, the Glenn shunt, and the Fontan procedure. These complex interventions are designed to reroute blood flow, enabling the single functioning ventricle to circulate blood throughout the body. While advancements in medical care have significantly improved survival rates for children with HLHS, allowing many to live into adulthood, the condition and its subsequent treatments can unfortunately lead to serious long-term complications, including significant liver damage and eventual liver failure.
Addressing the Long-Term Consequences of Congenital Heart Disease
Recognizing the progressive nature of complications associated with single-ventricle physiology, Children’s Colorado took proactive steps to address the ongoing health challenges faced by patients like Gracie. In 2016, the hospital established the Fontan Multidisciplinary Clinic as an integral component of its comprehensive Single Ventricle Program. This specialized clinic is dedicated to providing coordinated, holistic care for patients diagnosed with HLHS and other single ventricle conditions, such as tricuspid atresia and unbalanced atrioventricular canal defects. The clinic’s approach emphasizes a patient-centered model, ensuring that all aspects of a child’s health are meticulously monitored and managed by a dedicated team of experts.
Through the Fontan Multidisciplinary Clinic, Gracie received continuous, expert monitoring and treatment for both her heart and liver conditions. Her dedicated care team comprised leading specialists, including cardiologist Dr. Kathleen Simpson and hepatologist Dr. Dania Brigham. These physicians worked in close collaboration, pooling their expertise to manage Gracie’s complex health status and optimize her well-being until a dual organ transplant emerged as the most viable and beneficial option for her long-term health.
"The Fontan is a lifesaving surgery, but the longer someone lives after the procedure, there is an increased chance of developing comorbidities," explained Dr. Simpson. "Our care team worked diligently to keep her healthy and enable her to live a typical day-to-day life for as long as possible before we determined that a dual organ transplant would offer her the best possible long-term quality of life." This statement underscores the careful consideration and strategic planning that went into determining the optimal timing for Gracie’s transplant.
The Path to a Complex Dual Organ Transplant: A Detailed Chronology
The journey towards Gracie’s dual transplant involved a critical period of escalating health concerns and meticulous preparation. For years, Gracie lived with plastic bronchitis, a serious and often debilitating condition that causes the accumulation of thick, protein-rich material within the airways, hindering respiration. Over the past year, Gracie’s symptoms associated with plastic bronchitis significantly worsened, coinciding with the emergence of clear signs of liver failure. Faced with this progressive deterioration, her medical team concluded that proceeding with a dual heart and liver transplant was not only recommended but medically imperative. In April, Gracie was officially placed on the national transplant waitlist, marking the beginning of a race against time.
The period following Gracie’s placement on the waitlist was characterized by intense preparation and strategic planning. Dozens of highly specialized medical professionals convened regularly in a series of critical meetings. These sessions were dedicated to meticulously planning every aspect of the complex surgery. The team carefully analyzed and accounted for the unique challenges inherent in transplanting two vital organs simultaneously. These challenges included managing differences in blood volume requirements between the two organs, as well as precisely coordinating electrolyte balance throughout the extended surgical procedure to maintain Gracie’s stability and optimize her chances of success. This level of detailed planning is a hallmark of advanced transplant programs.
A Carefully Orchestrated 16-Hour Surgical Endeavor
The breakthrough in Gracie’s treatment came less than a month after her addition to the transplant waitlist when compatible donor organs became available. This life-saving opportunity was made possible by the selfless decision of another family to donate their loved one’s organs. Given the extremely limited viability window for a donor heart, the surgical team prioritized the heart transplant. This critical phase of the operation, lasting approximately nine hours, was led by Dr. Matthew Stone, surgical director of the Pediatric Heart Transplant Program, and congenital heart surgeon Dr. Emily Downs.
While the heart transplant was in progress, a specialized device known as the TransMedics Organ Care System played a crucial role in preserving the donor liver. This advanced technology effectively replicates the normal physiological functions of a liver, thereby extending its viability and allowing the surgical team sufficient time to complete the heart procedure without compromising the integrity of the liver graft. Once the heart transplant was successfully concluded, Dr. Adams and transplant surgeon Dr. Kendra Conzen took over to perform the liver transplant. This second phase of the surgery, equally demanding, lasted an additional seven hours. Throughout this entire meticulously orchestrated 16-hour surgical marathon, continuous and close coordination with the anesthesiology teams was absolutely essential to safeguard Gracie’s delicate health and ensure her physiological stability.
Recovery and the Promise of a Return to Everyday Life
The highly complex dual organ transplant was a resounding success, a testament to the skill and dedication of the Children’s Colorado medical team. Following the extensive surgery, Gracie was transferred to the cardiac progressive care unit. She remained there for just over a month, undergoing intensive monitoring and rehabilitation. Remarkably, within seven months of her transplant, Gracie has made a significant recovery. She has resumed attending school, re-engaging with her education, and has returned home to her beloved dogs, signifying a return to a semblance of normalcy and a life filled with renewed promise.
While Gracie, like many pediatric heart transplant recipients, may require a subsequent heart transplant later in her life due to the inherent limitations of artificial organs, the prognosis for her transplanted liver is exceptionally positive. It is anticipated that the new liver will function effectively for the remainder of her lifetime, offering her a substantial improvement in her quality of life and a significant reduction in her long-term health risks.
"This procedure showcases the expertise, talent, and level of care Children’s Colorado provides to our patients, including those with complex medical needs," remarked Dr. Duncan Wilcox, Surgeon in Chief at Children’s Colorado. "As the top-ranked pediatric hospital in Colorado and the Rocky Mountain region, we are proud of our leading-edge transplant care and look forward to supporting more patients who need dual organ transplants in the future." This statement from hospital leadership reinforces the institution’s commitment to pushing the boundaries of pediatric medicine and serving as a beacon of hope for children with the most complex medical conditions.
Broader Implications and Future of Pediatric Transplant Care
The successful dual heart and liver transplant at Children’s Colorado carries significant implications for the field of pediatric transplantation. It not only demonstrates the hospital’s advanced capabilities but also highlights the growing importance of multidisciplinary care models for children with complex congenital conditions. The rarity of such procedures underscores the need for specialized centers of excellence equipped with the expertise, technology, and collaborative spirit to undertake these life-saving interventions.
The use of advanced technologies, such as the TransMedics Organ Care System, during the transplant process further illustrates the innovative approaches being adopted to improve organ preservation and surgical outcomes. This technology allows for longer organ viability, expanding the window for transplantation and potentially increasing the number of successful procedures.
Furthermore, the establishment and continued success of programs like the Fontan Multidisciplinary Clinic are crucial for managing the long-term health of children born with congenital heart defects. By focusing on the holistic care of these patients, hospitals can proactively address potential complications, such as liver disease, and optimize their health trajectories, thereby reducing the need for emergency interventions and improving long-term survival and quality of life.
The milestone achieved by Children’s Colorado is a powerful reminder of the ongoing advancements in medical science and the profound impact of dedicated medical teams on the lives of children facing life-threatening illnesses. It sets a new benchmark for pediatric transplant care in the region and offers hope to families facing similar challenges, signifying a brighter future for children requiring complex organ support. The hospital’s commitment to innovation and its robust collaborative framework position it as a leader in providing critical care for the most vulnerable patient populations.